Evidence map›Paper›PMID 23055476›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes.

Rachel F Lane, Peter St George-Hyslop, Barbara L Hempstead, Scott A Small, Stephen M Strittmatter, Sam Gandy

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Iterative evolution ofSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Rachel F LaneAlzheimer's Drug Discovery Foundation, New York, New York 10019, USA. RLane@alzdiscovery.org
Peter St George-Hyslop
Barbara L Hempstead
Scott A Small
Stephen M Strittmatter
Sam Gandy
Alzheimer's Drug Discovery Foundation · USColumbia University · USCornell University · USJames J. Peters VA Medical Center · USUniversity of Toronto · CAYale University · US

Funding

Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
Prion Protein in Alzheimer's Disease PathophysiologyR01AG034924 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2010 to 2026
$9.6M
Role of Neurotrophins and Receptors in NeurogenesisR01NS030687 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HEMPSTEAD, BARBARA L · 1993 to 2014
$5.1M
MRI and mouse models of Alzheimer's disease and agingR01AG025161 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2005 to 2015
$3.0M
Progranulin interaction with Sortilin in FrontoTemporal DementiaR01NS074319 · NINDS · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2011 to 2015
$1.8M
Model for SorCS1-mediated Diabetes with DementiaR01NS075685 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GANDY, SAMUEL E. · 2012 to 2015
$1.5M
CIHRNIA NIH HHS AG025161NIA NIH HHS AG034924NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG008702NIA NIH HHS R01 AG025161NIA NIH HHS R01 AG034924NINDS NIH HHS NS030687NINDS NIH HHS NS074319NINDS NIH HHS NS075685NINDS NIH HHS R01 NS030687NINDS NIH HHS R01 NS074319NINDS NIH HHS R01 NS075685Wellcome Trust 081864
6 · The paper itself

Abstract

Members of the vacuolar protein sorting 10 (Vps10) family of receptors (including sortilin, SorL1, SorCS1, SorCS2, and SorCS3) play pleiotropic functions in protein trafficking and intracellular and intercellular signaling in neuronal and non-neuronal cells. Interactions have been documented between Vps10 family members and the retromer coat complex, a key component of the intracellular trafficking apparatus that sorts cargo from the early endosome to the trans-Golgi network. In recent years, genes encoding several members of the Vps10 family of proteins, as well as components of the retromer coat complex, have been implicated as genetic risk factors for sporadic and autosomal dominant forms of neurodegenerative diseases, including Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease, with risk for type 2 diabetes mellitus and atherosclerosis. In addition to their functions in protein trafficking, the Vps10 family proteins modulate neurotrophic signaling pathways. Sortilin can impact the intracellular response to brain-derived neurotrophic factor (BDNF) by regulating anterograde trafficking of Trk receptors to the synapse and direct control of BDNF levels, while both sortilin and SorCS2 function as cell surface receptors to mediate acute responses to proneurotrophins. This mini-review and symposium will highlight the emerging data from this rapidly growing area of research implicating the Vps10 family of receptors and the retromer in physiological intracellular trafficking signaling by neurotrophins and in the pathogenesis of neurodegeneration.

Indexed as

AgingAnimalsDiabetes Mellitus, Type 2HumansIntracellular SpaceNerve Growth FactorsNeural PathwaysNeurodegenerative DiseasesProtein TransportReceptors, Cell SurfaceSignal TransductionNerve Growth FactorsReceptors, Cell SurfaceSORCS1 protein, human

Identifiers

PMID23055476
PMCPMC3576841
OpenAlexW2095075524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.